A5061190318- Lung Cancer Diagnosis and Treatment
- Esophageal Cancer Research and Treatment
- Cancer Immunotherapy and Biomarkers
- Lung Cancer Research Studies
- Nutrition and Health in Aging
- Cancer survivorship and care
- Colorectal and Anal Carcinomas
- Radiomics and Machine Learning in Medical Imaging
- Pancreatic and Hepatic Oncology Research
- Neuroendocrine Tumor Research Advances
- Lung Cancer Treatments and Mutations
- Cancer-related gene regulation
- Prostate Cancer Diagnosis and Treatment
- Advanced Radiotherapy Techniques
Shandong First Medical University
2022-2025
Shandong Tumor Hospital
2022-2025
Second Hospital of Shandong University
2024
Shandong Academy of Chinese Medicine
2022
PURPOSE This multicenter, randomized, phase III clinical trial (Northern Radiation Oncology Group of China-002) focused on patients with oligo-organ metastatic non–small cell lung cancer (NSCLC) who have epidermal growth factor receptor ( EGFR ) mutations. We aimed to investigate whether first-line concurrent thoracic radiotherapy (TRT) and EGFR-tyrosine kinase inhibitors (TKIs), compared TKIs alone, could achieve better survival. MATERIALS AND METHODS The in the TKI plus TRT group received...
410 Background: Neoadjuvant chemotherapy or chemoradiotherapy followed by surgery is the standard of care for resectable locally advanced ESCC. SHR-1701, a new bifunctional fusion protein composed monoclonal antibody against PD-L1 fused with extracellular domain TGF-β receptor II, may enhance antitumor activity in combination neoadjuvant therapies ESCC patients (pts). The aim this phase II trial to determine safety and efficacy plus SHR-1701 esophagectomy pts Methods: Pts thoracic ESCC,...
Purpose To compare the difference between magnetic resonance imaging (MRI) and computed tomography (CT) in delineating target area of lung cancer with atelectasis. Method A retrospective analysis was performed on 15 patients accompanied by All positioning images were transferred to Eclipse treatment planning systems (TPSs). Six MRI sequences (T1WI, T1WI+C, T1WI+C Delay, 10 minutes, T2WI, DWI) registered CT. Five radiation oncologists delineated tumor boundary obtain gross volume (GTV)....
Although concurrent Chemoradiotherapy (cCRT) is presently the standard intervention for patients with inoperable, locally advanced Esophageal Squamous Cell Carcinoma (ESCC), it has been associated poor long-term survival outcomes. Notably, Immune Checkpoint Inhibitors (ICIs) improve of Cancer (EC) patients, manageable Adverse Effects (AEs). Herein, 90 residual pathology after radical simultaneous Radiotherapy (RT) inoperable/refused-to-operate ESCC were enrolled and randomized into two...